Article Versions Notes

Bohn J-P, Stolzlechner V, Göbel G, Willenbacher W, Pirklbauer M, Steiner N, Wolf D. Beta-2-Microglobulin Maintains Overall Survival Prediction in Binet A Stage Chronic Lymphocytic Leukemia Patients with Compromised Kidney Function in Both Treatment Eras of Chemoimmunotherapy and Targeted Agents. Cancers. 2024; 16(22):3744. https://doi.org/10.3390/cancers16223744

Bohn, Jan-Paul, Valentina Stolzlechner, Georg Göbel, Wolfgang Willenbacher, Markus Pirklbauer, Normann Steiner, and Dominik Wolf. 2024. "Beta-2-Microglobulin Maintains Overall Survival Prediction in Binet A Stage Chronic Lymphocytic Leukemia Patients with Compromised Kidney Function in Both Treatment Eras of Chemoimmunotherapy and Targeted Agents" Cancers 16, no. 22: 3744. https://doi.org/10.3390/cancers16223744

Bohn, J.-P., Stolzlechner, V., Göbel, G., Willenbacher, W., Pirklbauer, M., Steiner, N., & Wolf, D. (2024). Beta-2-Microglobulin Maintains Overall Survival Prediction in Binet A Stage Chronic Lymphocytic Leukemia Patients with Compromised Kidney Function in Both Treatment Eras of Chemoimmunotherapy and Targeted Agents. Cancers, 16(22), 3744. https://doi.org/10.3390/cancers16223744